Viewing Study NCT02572661


Ignite Creation Date: 2025-12-24 @ 12:55 PM
Ignite Modification Date: 2026-01-14 @ 4:09 PM
Study NCT ID: NCT02572661
Status: COMPLETED
Last Update Posted: 2019-06-27
First Post: 2014-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT)
Sponsor: The Netherlands Cancer Institute
Organization:

Study Overview

Official Title: Mapping of Sentinel Lymph Node Drainage Using SPECT to Tailor Highly-Selective Elective Nodal Irradiation in Node-Negative Neck of Patients With Head and Neck Cancer (SUSPECT)
Status: COMPLETED
Status Verified Date: 2019-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SUSPECT
Brief Summary: This study aims to explore the feasibility, safety and outcome of a non-invasive sentinel node mapping (SNM) to individually tailor the elective nodal irradiation (ENI) to the ipsilateral neck only and to exclude the contralateral negative neck from the irradiation fields when there is no draining sentinel node. Subsequently the dose to the salivary glands, mucosal area and the swallowing and chewing muscles and structures involved in voicing and articulation will significantly be reduced
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
N14SUS REGISTRY PTC View
NL51706.031.14 REGISTRY CCMO View